MARKET

AURX

AURX

Nuo Therapeutics
OTCMQB
1.700
+0.150
+9.68%
Closed 10:39 04/02 EDT
OPEN
1.600
PREV CLOSE
1.550
HIGH
1.700
LOW
1.600
VOLUME
1.40K
TURNOVER
2.34K
52 WEEK HIGH
3.100
52 WEEK LOW
1.000
MARKET CAP
82.09M
P/E (TTM)
-32.9457
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Nuo Therapeutics (AURX)
TipRanks · 1d ago
Nuo Therapeutics Secures New Debt Financing and Warrants
TipRanks · 01/26 21:49
Nuo Therapeutics Secures $1.6 Million Loan from Group of Lenders
Reuters · 01/26 21:26
Nuo Therapeutics Reports Key Governance Decisions at Meeting
TipRanks · 12/17/2025 16:27
Nuo Therapeutics Inc. Held Annual Shareholder Meeting
Reuters · 12/17/2025 16:09
Nuo Therapeutics Initiated at Buy by Roth Capital
Dow Jones · 12/16/2025 15:30
Nuo Therapeutics Price Target Announced at $3.00/Share by Roth Capital
Dow Jones · 12/16/2025 15:30
Roth Capital Initiates Coverage On Nuo Therapeutics with Buy Rating, Announces Price Target of $3
Benzinga · 12/16/2025 15:20
More
About AURX
Nuo Therapeutics, Inc. is a commercial stage medical device company. The Company is focused on developing and marketing products for chronic wound care primarily within the United States. It has commercialized cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's product, Aurix, is a biodynamic hematogel that uses a patient’s own platelets and plasma as a catalyst for healing. Its commercial offering consists of a point of care technology for the separation of autologous blood to produce a platelet-based therapy for use in the chronic wound care market. The Aurix System produces a platelet-rich plasma (PRP) gel at the point of care using the patient’s own platelets and plasma sourced from a small draw of peripheral blood. The Aurix PRP comprises a natural, endogenous complement of protein and non-protein signal molecules that are believed to contribute to effective healing.

Webull offers Nuo Therapeutics Inc stock information, including OTCMQB: AURX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AURX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AURX stock methods without spending real money on the virtual paper trading platform.